BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260213
DTEND;VALUE=DATE:20260216
DTSTAMP:20260405T162406
CREATED:20260122T144429Z
LAST-MODIFIED:20260122T144429Z
UID:10000612-1770940800-1771199999@oncodaily.com
SUMMARY:31st Annual Multidisciplinary Symposium on Breast Disease
DESCRIPTION:The 31st Annual Multidisciplinary Symposium on Breast Disease will take place February 13–15\, 2026\, at The Ritz Carlton\, Amelia Island\, FL.  \nThis premier event offers a comprehensive\, multidisciplinary overview of breast cancer diagnosis and treatment\, spanning surgical\, medical\, and radiation oncology\, as well as pathology\, radiology\, and patient advocacy. Designed for clinicians\, specialists\, and scientists involved in breast cancer care\, research\, and education\, the symposium will highlight current challenges\, emerging advances\, and innovative strategies across all stages of the disease. Participants will gain actionable insights into the latest diagnostic techniques\, treatment approaches\, and therapeutic developments\, enhancing their ability to deliver state-of-the-art care to patients. \nRegister Now.
URL:https://oncodaily.com/event/breast-disease-445024
LOCATION:The Ritz Carlton\, Amelia Island\, 4750 Amelia Island Parkway\, Amelia Island\, FL\, 32034\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/BeFunky-collage-2026-01-22T184442.845.webp
ORGANIZER;CN="University of Florida":MAILTO:cme-mail@ufl.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260213T090000
DTEND;TZID=America/New_York:20260213T100000
DTSTAMP:20260405T162406
CREATED:20260124T234537Z
LAST-MODIFIED:20260124T234545Z
UID:10000618-1770973200-1770976800@oncodaily.com
SUMMARY:Novel Reinduction Strategies for Relapsed B-ALL - Resonance
DESCRIPTION:The ALRCaN Global webinar\, titled “Novel reinduction strategies for relapsed B-ALL\,” is scheduled for Friday\, February 13\, 2026\, at 09:00 AM ET. This session features Dr. Laura E. Hogan\, who will lead a lively discussion on innovative approaches to reinduction therapy for patients with relapsed B-cell acute lymphoblastic leukemia. \nOrganized through Resonance Health and created by Ivana Cáceres\, the event is supported by a leadership team including Scott Howard\, Stacy Cooper\, Archie Bleyer\, and Dan Douer. The webinar serves as a global platform for clinicians and researchers to explore emerging therapeutic strategies and share insights on improving outcomes for this challenging patient population across various international time zones.
URL:https://oncodaily.com/event/relapsed-b-all-446530
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/Laura-E-Hogan.webp
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260214T083000
DTEND;TZID=America/Halifax:20260214T143000
DTSTAMP:20260405T162406
CREATED:20251218T153252Z
LAST-MODIFIED:20251218T153412Z
UID:10000513-1771057800-1771079400@oncodaily.com
SUMMARY:Best of SABCS – West
DESCRIPTION:Best of SABCS – West\, taking place February 14\, 2026\, at the Intercontinental San Francisco\, provides clinicians with the latest updates in breast cancer research\, diagnosis\, and treatment. \nThe program highlights recent clinical trial results\, advances in management of breast cancer subtypes\, and evidence-based strategies to optimize patient care\, offering AMA PRA Category 1 Credit through the University of Texas at San Antonio. \nRegister here.
URL:https://oncodaily.com/event/sabcs-430563
LOCATION:Intercontinental San Francisco\, 888 Howard Street\, San Francisco\, California\, 94103\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/BeFunky-collage-94.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260214T090000
DTEND;TZID=America/Halifax:20260214T170000
DTSTAMP:20260405T162406
CREATED:20260114T211119Z
LAST-MODIFIED:20260114T211132Z
UID:10000572-1771059600-1771088400@oncodaily.com
SUMMARY:2026 Precision Oncology Workshop: From Genomics to Therapeutics
DESCRIPTION:The 2026 Precision Oncology Workshop: From Genomics to Therapeutics is a high-impact clinical event focused on the translation of genetic data into innovative cancer treatments. \nOrganized by the Private Cancer Physicians of Australia (PCPA) in collaboration with LifeStrands Genomics\, the workshop is scheduled for February 14\, 2026\, in Brisbane. The program is specifically designed for medical oncologists\, pathologists\, and geneticists\, providing a comprehensive deep dive into the human genome\, pharmacogenomics\, and the selection of appropriate molecular tests. \nRegister.
URL:https://oncodaily.com/event/precision-oncology-workshop-441160
LOCATION:InterContinental Brisbane\, 190 Elizabeth St\, Brisbane\, Brisbane\, QLD 4000\, Australia
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/PCPA-1.webp
ORGANIZER;CN="Private Cancer Physicians of Australia (PCPA)":MAILTO:pcpa@amaq.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Kolkata:20260215T160000
DTEND;TZID=Asia/Kolkata:20260215T170000
DTSTAMP:20260405T162406
CREATED:20260214T122914Z
LAST-MODIFIED:20260214T130840Z
UID:10000653-1771171200-1771174800@oncodaily.com
SUMMARY:ICCD 2026 National Webinar: From Policy to Practice in Childhood Cancer Care
DESCRIPTION:On the occasion of International Childhood Cancer Day (ICCD) 2026\, observed globally on 15 February to raise awareness and promote equitable access to quality cancer care for every child\, a National Webinar will convene leading experts and advocates from across India. \nCentered on the theme\, “From Policy to Practice: What Do We Really Need to Improve Childhood Cancer Care in India?” the virtual session (15 February 2026 | 4:00–5:00 PM IST) will focus on translating policy frameworks into real-world improvements in diagnosis\, treatment access\, survivorship\, and patient support systems. \nKey Highlights: \nKeynote Address: Dr. Ravi Kannan – Padma Shri Awardee\, Cancer Care Visionary and Public Health Leader \nSession Chair: Dr. Satya Yadav – Chairperson\, PHO–IAP \nSession Moderator: Dr. Shweta Bansal – Secretary\, PHO–IAP \nPanelists: \n\nDr. Gevorg Tamamyan – Editor-in-Chief\, OncoDaily; President\, POEM Group and SIOP Asia\nDr. Rejin Kubudi – General Secretary\, SIOP Society\nDr. Rajesh Kasle – Senior Pediatrician; President\, IAP Mumbai\nDr. Girish Chinnaswamy – Head\, PHO\, TMH Mumbai\nAlka Bisen – CEO\, CPAA (Cancer Patients Aid Association)\n\nBringing together clinicians\, public health leaders\, and patient advocates\, the webinar aims to foster actionable dialogue and collaborative strategies to strengthen childhood cancer care delivery across India.
URL:https://oncodaily.com/event/childhood-cancer-455577
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/02/BeFunky-collage-2026-02-14T164300.761-1280x720-1-1.webp
ORGANIZER;CN="Pediatric Hematology &amp%3B Oncology (PHO) Chapter of the Indian Academy of Pediatrics (IAP)":MAILTO:secy.pho@gmail.com
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260216
DTEND;VALUE=DATE:20260219
DTSTAMP:20260405T162406
CREATED:20251204T143844Z
LAST-MODIFIED:20251204T143910Z
UID:10000446-1771200000-1771459199@oncodaily.com
SUMMARY:SCION Workshop 2026
DESCRIPTION:The SITC Clinical Immuno-Oncology Network (SCION) Workshop is an intimate\, intensive clinical trial development program organized by the Society for Immunotherapy of Cancer (SITC)\, designed to address the unique challenges in designing protocols specific to cancer immunotherapy. \nThe 2026 SCION Workshop is scheduled for February 16-18\, 2026\, and will be held at The Westin Copley Place\, Boston. Participation requires an application with a proposed protocol abstract and includes a mandatory 90-day post-workshop report to ensure progress in clinical trial development.
URL:https://oncodaily.com/event/scion-421390
LOCATION:The Westin Copley Place\, Boston\, 10 Huntington Avenue\, Boston\, MA\, 02116\, United States
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/08/16_9-1.jpg
ORGANIZER;CN="Society for Immunotherapy of Cancer":MAILTO:info@sitcancer.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260217
DTEND;VALUE=DATE:20260319
DTSTAMP:20260405T162406
CREATED:20260122T145425Z
LAST-MODIFIED:20260122T145425Z
UID:10000613-1771286400-1773878399@oncodaily.com
SUMMARY:ASTRO's Multidisciplinary Radiopharmaceutical Therapy Symposium
DESCRIPTION:The Multidisciplinary Radiopharmaceutical Therapy Symposium (MRPTS) will be held February 17–18\, 2026\, at JW Marriott Desert Springs\, Palm Desert\, California\, with a live virtual option for remote attendees. \nThis inaugural symposium brings together experts across disciplines to explore the evolving use and latest advancements in radiopharmaceuticals for cancer and other indications. Under the theme “From Start-Up to State-of-the-Art: A Collaborative Journey\,” participants will gain insights into translational research\, clinical applications\, and collaborative innovations driving the next generation of radiopharmaceutical therapies. \nRegister Now.
URL:https://oncodaily.com/event/radiopharmaceutical-therapy-445044
LOCATION:JW Marriott Desert Springs Resort & Spa\, 74-855 Country Club Drive\, Palm Desert\, CA\, 92260\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/Annotation-2026-01-22-185402.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260218
DTEND;VALUE=DATE:20260219
DTSTAMP:20260405T162406
CREATED:20251227T145119Z
LAST-MODIFIED:20251227T145133Z
UID:10000537-1771372800-1771459199@oncodaily.com
SUMMARY:ESMO Therapeutic Landscapes: Toxicity of Multispecific Antibodies and Immune-Cell Engagers 2026
DESCRIPTION:ESMO Therapeutic Landscapes: Toxicity of Multispecific Antibodies and Immune-Cell Engagers 2026 is a specialized technical webinar scheduled for February 18\, 2026\, focused on the safety profiles and clinical management of next-generation biologics. \nChaired by Elena Garralda\, the program features expert discussions on the molecular mechanisms of on-target/off-tumor effects and evaluates emerging mitigation strategies to optimize patient outcomes. This virtual event\, part of the ESMO Therapeutic Landscapes series\, provides attendees with 1 ESMO-MORA category 1 point and serves as a vital forum for clinicians to refine their expertise in navigating the complexities of modern immunotherapy toxicity. \nRegister.
URL:https://oncodaily.com/event/esmo-therapeutic-landscapes-434705
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-Therapeutic-Landscapes.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260218
DTEND;VALUE=DATE:20260220
DTSTAMP:20260405T162406
CREATED:20251126T002120Z
LAST-MODIFIED:20251126T002132Z
UID:10000403-1771372800-1771545599@oncodaily.com
SUMMARY:ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2026: Lugano
DESCRIPTION:The ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2026: Lugano is a two-day educational course focusing on the management of metastatic bladder and kidney cancer\, providing oncologists with a thorough understanding of current standards of care\, molecular pathology\, and novel treatment targets. \nThe preceptorship will take place on February 18–19\, 2026\, in Lugano\, Switzerland\, and is accredited with ESMO-MORA category 1 points. Successful applicants receive complimentary course registration and accommodation. The application deadline for this event is December 11\, 2025. \nApply.
URL:https://oncodaily.com/event/esmo-preceptorship-416470
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/esmo-1-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260218
DTEND;VALUE=DATE:20260221
DTSTAMP:20260405T162406
CREATED:20260126T011556Z
LAST-MODIFIED:20260126T011603Z
UID:10000624-1771372800-1771631999@oncodaily.com
SUMMARY:Advancing Cancer Research for Latinos and All Populations
DESCRIPTION:The Advancing Cancer Research for Latinos and All Populations conference is a biennial international event scheduled for February 18-20\, 2026\, in San Antonio\, Texas. \nHosted by the Mays Cancer Center and the Institute for Health Promotion Research at UT Health San Antonio\, this conference addresses the critical health disparities facing Latinos\, for whom cancer remains a leading cause of death\, and who often face significant barriers to screening\, treatment\, and palliative care. The summit unites a diverse group of stakeholders – including survivors\, caregivers\, researchers\, and physicians – to translate basic research into clinical best practices and effective community interventions. \nRegister.
URL:https://oncodaily.com/event/advancing-cancer-research-447028
LOCATION:Plaza San Antonio Hotel & Spa\, Autograph Collection\, 555 S Alamo St\, San Antonio\, TX\, 78205\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/Latinos.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260218
DTEND;VALUE=DATE:20260222
DTSTAMP:20260405T162406
CREATED:20251102T220138Z
LAST-MODIFIED:20251102T220151Z
UID:10000308-1771372800-1771718399@oncodaily.com
SUMMARY:Targeted Therapies of Lung Cancer 2026
DESCRIPTION:The Targeted Therapies of Lung Cancer (TTLC) 2026 Meeting\, organized by the International Association for the Study of Lung Cancer (IASLC)\, is a premier event for experts dedicated to advancing lung cancer care. The meeting is scheduled to begin on February 18\, 2026\, and will be held in Huntington Beach\, California. The conference is a must-attend event that brings together leading researchers\, clinicians\, and industry experts to share the latest breakthroughs in clinical research\, focusing on innovation in targeted therapies for thoracic malignancies. \nYou can find more posts featuring IASLC on OncoDaily.
URL:https://oncodaily.com/event/targeted-therapies-402227
LOCATION:Hyatt Regency Huntington Beach Resort And Spa\, 21500 Pacific Coast Hwy\, Huntington Beach\, CA\, 92648\, United States
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/10/IASLC.jpg
ORGANIZER;CN="International Association for the Study of Lung Cancer (IASCL)":MAILTO:info@iaslc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260218
DTEND;VALUE=DATE:20260222
DTSTAMP:20260405T162406
CREATED:20251222T215456Z
LAST-MODIFIED:20251222T215529Z
UID:10000521-1771372800-1771718399@oncodaily.com
SUMMARY:Targeted Therapies of Lung Cancer (TTLC 2026)
DESCRIPTION:The IASLC 2026 Targeted Therapies of Lung Cancer (TTLC) meeting is a premier international conference scheduled for February 18–21\, 2026\, in Huntington Beach\, California. \nOrganized by the International Association for the Study of Lung Cancer (IASLC)\, this landmark event brings together global experts\, clinicians\, and researchers to share the latest breakthroughs in preclinical research and data from cutting-edge clinical trials. The symposium serves as a critical forum for discussing how emerging molecular targets and novel treatments are actively transforming clinical practice and treatment guidelines for thoracic malignancies. \nRegister.
URL:https://oncodaily.com/event/targeted-therapies-of-lung-cancer-432816
LOCATION:Hyatt Regency Huntington Beach Resort And Spa\, 21500 Pacific Coast Hwy\, Huntington Beach\, CA\, 92648\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/TTLC-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260218T080000
DTEND;TZID=America/Halifax:20260221T170000
DTSTAMP:20260405T162406
CREATED:20250717T130123Z
LAST-MODIFIED:20250717T130143Z
UID:10000220-1771401600-1771693200@oncodaily.com
SUMMARY:AACR IO Conference 2026
DESCRIPTION:The AACR IO Conference 2026\, titled Discovery and Innovation in Cancer Immunology: Revolutionizing Treatment through Immunotherapy\, will take place from February 18–21\, 2026\, at JW Marriott Los Angeles L.A. Live.  \nLed by Scientific Committee Chairs Nina Bhardwaj and Antoni Ribas\, the event will focus on cutting-edge research in cancer immunology\, highlighting breakthroughs in immuno-oncology (IO) drugs\, inflammatory modulators\, vaccines\, and cellular therapies. \nBuilding on the success of AACR IO 2025\, which drew over 600 participants\, AACR IO 2026 promises a comprehensive program including keynote lectures\, symposia\, spotlight sessions\, educational content\, and poster presentations. This forum offers a valuable opportunity for scientists\, clinicians\, industry leaders\, and advocates to engage with the latest advances in cancer immunotherapy. \nMore posts featuring AACR.
URL:https://oncodaily.com/event/aacr-io-conference-2026-331172
LOCATION:JW Marriott Los Angeles L.A. Live\, 900 W Olympic Blvd\, Los Angeles\, CA\, Los Angeles\, 90015\, United States
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/07/download-7.png
ORGANIZER;CN="American Association for Cancer Research":MAILTO:aacr@aacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260218T081500
DTEND;TZID=America/Halifax:20260220T190000
DTSTAMP:20260405T162406
CREATED:20251213T013628Z
LAST-MODIFIED:20251213T013743Z
UID:10000484-1771402500-1771614000@oncodaily.com
SUMMARY:2026 International Cancer Neuroscience Symposium
DESCRIPTION:The 2026 International Cancer Neuroscience Symposium\, hosted by The University of Texas MD Anderson Cancer Center Cancer Neuroscience Program and Wiley’s Advanced Portfolio\, is a three-day dynamic hybrid event scheduled for Wednesday\, February 18\, to Friday\, February 20\, 2026. \nThe in-person component will be held at the TMC3 Collaborative Building in Houston\, Texas. This biennial symposium aims to integrate the fields of oncology\, neuroscience\, cancer biology\, neuroimmunology\, and mental health\, bringing together over 30 leading international experts to share key insights and cutting-edge research to foster innovation in cancer research and enhance patient care. \nRegister.
URL:https://oncodaily.com/event/international-cancer-neuroscience-symposium-426891
LOCATION:TMC3 Collaborative Building\, 7255 Helix Park Ave\, Houston\, TX\, 77030\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/1754434517156.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260219
DTEND;VALUE=DATE:20260222
DTSTAMP:20260405T162406
CREATED:20251026T210410Z
LAST-MODIFIED:20251026T210435Z
UID:10000291-1771459200-1771718399@oncodaily.com
SUMMARY:2026 Multidisciplinary Head and Neck Cancers Symposium by ASTRO
DESCRIPTION:The 2026 Multidisciplinary Head and Neck Cancers Symposium is a two-and-a-half-day event scheduled for February 19-21\, 2026. Organized by ASTRO (American Society for Radiation Oncology) and co-sponsored by other key medical societies\, the symposium will be held both in-person in Palm Desert\, California\, and as a live virtual meeting online. \nThe central theme for the 2026 meeting is “Advancing Patient-Centered Care Through Innovative Team Science.” The conference aims to foster meaningful collaboration among radiation oncologists\, medical oncologists\, surgeons\, and other specialists to share the most current\, evidence-based practices in the field. \nThe program is structured to deliver practical insights through educational sessions\, interactive case discussions\, and oral abstract presentations. It serves as a forum for presenting and discussing new data\, with the Call for Abstracts remaining open until October 8\, 2025. The core objective of the symposium is to improve patient outcomes by advancing multidisciplinary treatment approaches and team-based care for head and neck cancers. Registration and housing are currently open for attendees.
URL:https://oncodaily.com/event/head-and-neck-cancers-398768
LOCATION:JW Marriott Desert Springs Resort and Spa\, 74-855 Country Club Dr.\, Palm Desert\, CA\, 92260\, United States
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/10/image-25.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260219T120000
DTEND;TZID=America/Halifax:20260219T130000
DTSTAMP:20260405T162406
CREATED:20251210T223125Z
LAST-MODIFIED:20251210T223148Z
UID:10000471-1771502400-1771506000@oncodaily.com
SUMMARY:Advocates Webinar: Modernizing Oncology Endpoints
DESCRIPTION:The Advocates Webinar: Modernizing Oncology Endpoints\, hosted virtually by Friends of Cancer Research (Friends)\, is a free\, advocates-focused session scheduled for Thursday\, February 19\, 2026\, from 12:00 PM to 1:00 PM ET. \nThe webinar will build upon the public meeting held earlier in the month\, focusing on translating complex scientific and policy discussions into accessible\, advocacy-focused insights concerning two emerging tools in cancer drug development: circulating tumor DNA (ctDNA) and Artificial Intelligence (AI)-based tumor assessment tools. The goal is to explain how these biomarkers and technologies can accelerate evidence generation and clinical trial efficiency to support earlier patient access to treatments. \nRegister.
URL:https://oncodaily.com/event/advocates-webinar-425835
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/webinar.webp
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260219T190000
DTEND;TZID=America/New_York:20260219T200000
DTSTAMP:20260405T162406
CREATED:20260126T012807Z
LAST-MODIFIED:20260126T012831Z
UID:10000626-1771527600-1771531200@oncodaily.com
SUMMARY:Closing the Gap in Geriatric Oncology: Recent Advances and Challenges in Implementing Geriatric Oncology Principles in Routine Cancer Care
DESCRIPTION:The Multinational Association of Supportive Care in Cancer (MASCC)\, in partnership with SIOG-NAHS and JASCC Geriatrics\, will host a webinar titled “Closing the Gap in Geriatric Oncology: Recent Advances and Challenges in Implementing Geriatric Oncology Principles in Routine Cancer Care“. \nScheduled for Thursday\, February 19\, 2026\, the session runs from 7:00 PM to 8:00 PM EST. The agenda includes discussions on geriatric assessment in Japan and evidence-based integrative medicine\, featuring a panel led by co-chairs Dr. Ayumu Matsuoka and Dr. Sriram Yennu\, alongside Dr. Lisa Guccione and Dr. Kelly McConnell.
URL:https://oncodaily.com/event/geriatric-oncology-447041
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/MASCC-1.webp
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260220
DTEND;VALUE=DATE:20260222
DTSTAMP:20260405T162406
CREATED:20251201T203902Z
LAST-MODIFIED:20251201T203902Z
UID:10000435-1771545600-1771718399@oncodaily.com
SUMMARY:APPOS Las Vegas 2026: Advanced Practice Providers Oncology Summit
DESCRIPTION:The APPOS Las Vegas 2026: Advanced Practice Providers Oncology Summit is a two-day continuing medical education conference organized by Horizon CME\, scheduled for February 20th – 21st\, 2026\, at the Circa Resort and Casino in Las Vegas\, Nevada. \nThe summit is specifically tailored for Advanced Practice Providers (APPs)\, including Nurse Practitioners (NPs)\, Physician Assistants (PAs)\, pharmacists\, and nurses\, with the primary goal of providing the latest evidence-based strategies to optimize care and outcomes for patients with cancer. \nRegister.
URL:https://oncodaily.com/event/419963
LOCATION:Circa Resort & Casino\, 8 Fremont St\, Las Vegas\, NV\, 89101\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/APPOS-Las-Vegas.webp
ORGANIZER;CN="Horizon CME":MAILTO:info@horizoncme.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260220
DTEND;VALUE=DATE:20260222
DTSTAMP:20260405T162406
CREATED:20251209T213259Z
LAST-MODIFIED:20251209T213315Z
UID:10000467-1771545600-1771718399@oncodaily.com
SUMMARY:Highlights in GI Oncology
DESCRIPTION:The Highlights in GI Oncology conference\, hosted by Horizon CME\, is a two-day educational program providing the latest science and practice-changing advances from the world’s premier GI oncology event\, the ASCO Gastrointestinal Cancers Symposium. \nThe CME initiative\, designed for a multidisciplinary audience including oncologists\, surgeons\, and nurses\, is scheduled for February 20–21\, 2026\, at the Orlando World Center Marriott. Expert faculty will review the most recent research and treatment strategies for various GI cancers\, including colorectal\, pancreatic\, biliary\, and neuroendocrine cancers\, applying the findings to patient case contexts. \nRegister.
URL:https://oncodaily.com/event/highlights-in-gi-oncology-425076
LOCATION:Orlando World Center Marriott\, 8701 World Center Dr\, Orlando\, FL\, 32821\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/Screenshot-2025-12-10-013028.webp
ORGANIZER;CN="Horizon CME":MAILTO:info@horizoncme.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260220
DTEND;VALUE=DATE:20260222
DTSTAMP:20260405T162406
CREATED:20251215T185942Z
LAST-MODIFIED:20251215T185950Z
UID:10000497-1771545600-1771718399@oncodaily.com
SUMMARY:Oncology APP Leadership Forum 2026
DESCRIPTION:The Oncology APP Leadership Forum 2026 is the 3rd annual two-day conference designed for current and aspiring Advanced Practice Provider (APP) leaders\, managers\, administrators\, and directors in oncology. \nScheduled for February 20–21\, 2026\, at the Circa Resort and Casino in Las Vegas\, the forum focuses on equipping APP leaders with the knowledge and skills to become more effective leaders in their organizations. Key topics on the agenda include critical conversations in the workplace\, utilizing AI in leadership\, constructing an APP billing dashboard\, building leadership education frameworks\, and a workshop on burnout and boundary setting. \nRegister.
URL:https://oncodaily.com/event/oncology-app-leadership-forum-429017
LOCATION:Circa Resort & Casino\, 8 Fremont St\, Las Vegas\, NV\, 89101\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/Oncology-APP-Leadership-Forum-2026.webp
ORGANIZER;CN="Horizon CME":MAILTO:info@horizoncme.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260220
DTEND;VALUE=DATE:20260222
DTSTAMP:20260405T162406
CREATED:20251224T105230Z
LAST-MODIFIED:20251224T105245Z
UID:10000524-1771545600-1771718399@oncodaily.com
SUMMARY:5th CECOG Breast Cancer Academy
DESCRIPTION:The 5th CECOG Breast Cancer Academy\, organized by the Central European Cooperative Oncology Group (CECOG)\, is a specialized educational event taking place on February 20-21\, 2026\, in Vienna\, Austria. \nHeld at the ARCOTEL AQ\, the academy is designed for oncology professionals to explore current standards and emerging challenges in both early and advanced breast cancer management. Led by a scientific committee of Austrian experts\, the program features expert-led sessions on clinical scenarios and offers CME accreditation to enhance the professional development of its participants.
URL:https://oncodaily.com/event/cecog-breast-cancer-433294
LOCATION:ARCOTEL AQ\, Althanstraße 8\, Vienna\, Vienna\, 1090\, Austria
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/CECOG.webp
ORGANIZER;CN="Central European Cooperative Oncology Group (CECOG)":MAILTO:office@cecog.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260220T090000
DTEND;TZID=America/New_York:20260220T100000
DTSTAMP:20260405T162406
CREATED:20260124T234805Z
LAST-MODIFIED:20260124T234834Z
UID:10000619-1771578000-1771581600@oncodaily.com
SUMMARY:CAR T-Cell Therapy to Transplant: Evolving Therapy for AYA Leukemia - Resonance
DESCRIPTION:The ALRCaN Global webinar\, titled “CAR T-Cell Therapy to Transplant: Evolving Therapy for AYA Leukemia\,” is scheduled for Friday\, February 20\, 2026\, at 09:00 AM ET. Featuring Dr. Hannah Lust\, the session will focus on the evolving treatment landscape for Adolescent and Young Adult (AYA) patients\, specifically examining the transition and relationship between CAR T-cell therapy and hematopoietic stem cell transplantation. \nHosted by Resonance Health and created by Ivana Cáceres\, the event is supported by the leadership of Scott Howard\, Stacy Cooper\, Archie Bleyer\, and Dan Douer. This discussion provides a global forum for oncology professionals to explore integrated therapeutic strategies aimed at optimizing long-term outcomes for the AYA leukemia population.
URL:https://oncodaily.com/event/car-t-cell-therapy-446541
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/Hannah-Lust.webp
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260223
DTEND;VALUE=DATE:20260227
DTSTAMP:20260405T162406
CREATED:20251031T111100Z
LAST-MODIFIED:20251117T094309Z
UID:10000304-1771804800-1772150399@oncodaily.com
SUMMARY:16th World ADC London
DESCRIPTION:The 16th World ADC London\, set to convene at ExCeL London from February 23–26\, 2026\, stands as Europe’s premier conference dedicated to Antibody-Drug Conjugates (ADCs). The central focus of the 2026 event is differentiation across the ADC value chain – from design to production – in response to the dominance of Topo1 and MMAE payloads and the rising threat of resistance. \nThe summit will host over 800 senior European ADC decision-makers\, including biopharma executives\, clinicians\, investors\, and regulators. The comprehensive agenda features five streams covering the entire lifecycle of ADCs\, specifically highlighting novel cytotoxic and non-cytotoxic payloads\, dual/bispecific ADCs\, non-antibody conjugates\, and strategies for advancing these targeted therapies into earlier-line oncology treatments for maximum patient impact. \nThe 16th World ADC London event is expected to feature 800+ ADC Industry Attendees representing 240+ Companies in the Room\, with presentations delivered by a 120+ Global Speaker Faculty. The agenda includes 14+ Hours of Networking\, offering comprehensive One-on-One Partnering and informal networking opportunities\, spread across 4 Days of ADC Insights. The content is organized into 5 Tracks of End-to-End ADC Content. \nView the 2026 agenda here. \nRegistration link. \nFull Event Guide link. \nYou can find more posts on ADCs on OncoDaily.
URL:https://oncodaily.com/event/world-adc-london-401035
LOCATION:ExCeL London\, One Western Gateway\, Royal Victoria Dock\, London\, E16 1XL\, United Kingdom
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/10/World-ADC-London-Banner.jpg
ORGANIZER;CN="Hanson Wade Limited":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260224
DTEND;VALUE=DATE:20260225
DTSTAMP:20260405T162406
CREATED:20260126T225512Z
LAST-MODIFIED:20260126T225524Z
UID:10000631-1771891200-1771977599@oncodaily.com
SUMMARY:Innovations and Clinical Advances in Radioligand Therapy
DESCRIPTION:The OncoCorner webinar\, titled “Innovations and clinical advances in radioligand therapy\,” is scheduled for Tuesday\, February 24\, 2026\, starting at 18:00 CET. This session explores the rapid evolution of Radioligand Therapy (RLT)\, focusing on how translational research is enhancing targeting precision and integrating nuclear medicine more deeply into modern oncology. \nParticipants will gain insights into current capabilities at leading cancer centers\, expected breakthroughs over the next several years\, and the most promising emerging agents in the RLT landscape. The event features an expert panel consisting of Antoine Leimgruber\, Saverio Braccini\, Anne-Laure Giraudet\, and Niklaus Schaefer\, and is supported by Sharing Progress in Cancer Care (SPCC) as part of its Sustaining Corporate Programme.
URL:https://oncodaily.com/event/radioligand-therapy-447592
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/SPCC-6.webp
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260224
DTEND;VALUE=DATE:20260226
DTSTAMP:20260405T162406
CREATED:20251109T185330Z
LAST-MODIFIED:20251109T185345Z
UID:10000333-1771891200-1772063999@oncodaily.com
SUMMARY:Next Generation Immunotherapies: From Innovative Approaches to Overcoming Resistance and Beyond
DESCRIPTION:The Next Generation Immunotherapies: From Innovative Approaches to Overcoming Resistance and Beyond is the European Association for Cancer Research’s (EACR) inaugural virtual conference on this topic\, scheduled for February 24–25\, 2026. \nThe two-day virtual summit is dedicated to showcasing cutting-edge developments in immunotherapy\, spanning from basic research to clinical applications\, with a strong emphasis on addressing resistance – a common challenge in current cancer treatment. \nThe program will feature invited talks from leading scientists on innovative therapeutic strategies\, including novel NK\, T\, and myeloid cell therapies\, mRNA therapies\, cytokine targeting\, and new combinatorial immune checkpoint blockade strategies.
URL:https://oncodaily.com/event/next-generation-immunotherapies-406112
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/EACR-2.jpg
ORGANIZER;CN="European Association for Cancer Research":MAILTO:jane.smith@eacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260224
DTEND;VALUE=DATE:20260227
DTSTAMP:20260405T162406
CREATED:20251110T130152Z
LAST-MODIFIED:20260304T124024Z
UID:10000334-1771891200-1772150399@oncodaily.com
SUMMARY:9th CAR-TCR Summit Europe 2026
DESCRIPTION:The 9th CAR-TCR Summit Europe 2026 is the essential\, industry-dedicated forum for next-generation cell therapy\, scheduled from February 24–26\, 2026\, in London\, UK\, at the Park Plaza Victoria hotel. Organized by Hanson Wade\, the summit unites developers from Europe and Asia with an end-to-end focus on accelerating clinical success by exploring cutting-edge scientific insights and practical strategies\, including novel CAR\, TCR\, NK\, and Macrophage designs\, engineering to improve durability\, and solutions to overcome bottlenecks in manufacturing\, regulatory approval\, and commercialization. \nFull Event Guide Link. \nThis article is sponsored by Hanson Wade Group.
URL:https://oncodaily.com/event/car-tcr-summit-406640
LOCATION:Park Plaza Victoria London\, 239 Vauxhall Bridge Road\, London\, Greater London (England)\, SW1V 1EQ\, United Kingdom
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/11/9th-CAR-TCR-Summit-Europe-2026.png
ORGANIZER;CN="Hanson Wade Limited":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260224
DTEND;VALUE=DATE:20260227
DTSTAMP:20260405T162406
CREATED:20251213T014339Z
LAST-MODIFIED:20251213T014358Z
UID:10000485-1771891200-1772150399@oncodaily.com
SUMMARY:Colorectal Liver Metastasis Consensus Conference
DESCRIPTION:The Colorectal Liver Metastasis Consensus Conference\, based on the Danish-Zurich model\, is a three-day in-person conference dedicated to advancing care\, research\, and building consensus for the treatment of colorectal liver metastases. Scheduled from Tuesday\, February 24\, to Thursday\, February 26\, 2026\, the meeting will be held at the TMC3 Collaborative Building (7255 Helix Park Ave.) in Houston\, Texas. \nHosted by The University of Texas MD Anderson Cancer Center\, the primary goal is to establish guidelines for the treatment of and research related to colorectal cancer liver metastases\, culminating in a consensus statement brought forth by leading experts\, clinicians\, and researchers in the field. \nRegister.
URL:https://oncodaily.com/event/colorectal-liver-metastasis426895
LOCATION:TMC3 Collaborative Building\, 7255 Helix Park Ave\, Houston\, TX\, 77030\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/md.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260224
DTEND;VALUE=DATE:20260227
DTSTAMP:20260405T162406
CREATED:20251222T221627Z
LAST-MODIFIED:20251222T221637Z
UID:10000523-1771891200-1772150399@oncodaily.com
SUMMARY:Data-Driven Cancer Research Conference
DESCRIPTION:The Data-Driven Cancer Research Conference is a comprehensive three-day scientific event hosted by Cancer Research UK in partnership with the EACR (European Association for Cancer Research)\, scheduled for February 24–26\, 2026. \nSet in the historic city of Edinburgh\, the conference explores the intersection of data science and oncology\, featuring expert-led discussions on AI-accelerated early detection\, digital twins\, and inclusive precision medicine. The program aims to foster global collaboration among bioinformaticians\, computational oncologists\, and researchers to address shared challenges in patient data transparency and pediatric cancer. \nRegister.
URL:https://oncodaily.com/event/data-driven-cancer-research-432826
LOCATION:Edinburgh International Conference Centre (EICC)\, 150 Morrison St\, Edinburgh\, EH3 8EE
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/EACR.webp
ORGANIZER;CN="Cancer Research UK":MAILTO:supporter.services@cancer.org.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260225
DTEND;VALUE=DATE:20260226
DTSTAMP:20260405T162406
CREATED:20251126T002352Z
LAST-MODIFIED:20251126T002404Z
UID:10000404-1771977600-1772063999@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases - Webinar Series: Gastroesophageal Cancer 2026
DESCRIPTION:The ESMO Guidelines: Real World Cases – Webinar Series: Gastroesophageal Cancer 2026 is a virtual event designed to help medical professionals apply the latest ESMO Clinical Practice Guidelines to the complex management of gastroesophageal cancers using real-world clinical cases. \nThe webinar will be broadcast live virtually on February 25\, 2026\, at 18:30 CET. The discussion will focus on the complexities and evolving areas of practice\, such as optimal biomarker testing\, the integration of immunotherapy\, and the management of treatment-related toxicities. \nRegister.
URL:https://oncodaily.com/event/esmo-guidelines-416474
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/esmo.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260225
DTEND;VALUE=DATE:20260226
DTSTAMP:20260405T162406
CREATED:20260131T002619Z
LAST-MODIFIED:20260131T002640Z
UID:10000651-1771977600-1772063999@oncodaily.com
SUMMARY:British Society of Haematology Supportive Care Specialist Interest Group (SIG) Prioritisation Workshop
DESCRIPTION:The British Society of Haematology Supportive Care Specialist Interest Group (SIG) Prioritisation Workshop is scheduled for Wednesday\, February 25\, 2026\, in London. \nThis face-to-face event is designed for members of the haematology community with a specialist interest in supportive care – ranging from pain and infection management to psychological and social support – to meet and network in person. The primary objective of the workshop is to collaborate on developing the SIG’s strategy for the coming years\, ensuring that multidisciplinary expertise continues to improve education\, training\, and clinical practice for patients with blood disorders across the UK. \nChaired by Laura Miller\, the SIG committee includes a diverse group of professionals such as Shireen Kassam\, Priya Sriskandarajah\, and Jennifer Vidrine\, who will lead discussions on embedding high standards of supportive care throughout the patient treatment pathway.
URL:https://oncodaily.com/event/british-society-of-haematology-449715
LOCATION:Friends House in Euston\, 173-177 Euston Rd.\, London\, NW1 2BJ\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/BSH.webp
ORGANIZER;CN="British Society of Haematology":MAILTO:info@b-s-h.org.uk
END:VEVENT
END:VCALENDAR